Bio-Techne
TECH
#1599
Rank
$9.77 B
Marketcap
$62.21
Share price
-0.83%
Change (1 day)
-26.23%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

P/E ratio for Bio-Techne (TECH)

P/E ratio as of April 2024 (TTM): 39.6

According to Bio-Techne's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.6242. At the end of 2022 the company had a P/E ratio of 49.6.

P/E ratio history for Bio-Techne from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202249.6-48.47%
202196.238.09%
202069.662.43%
201942.9-24.75%
201857.035.46%
201742.1-9.6%
201646.538.04%
201533.714.55%
201429.4-3.64%
201330.533.61%
201222.92.13%
201122.42.24%
201021.9-10.6%
200924.57.4%
200822.8-18.19%
200727.90.02%
200627.9-10.56%
200531.211.33%
200428.0-9.06%
200330.8-21.34%
200239.1-6.57%
200141.9

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
35.3-10.91%๐Ÿ‡บ๐Ÿ‡ธ USA
42.0 6.02%๐Ÿ‡บ๐Ÿ‡ธ USA
17.9-54.86%๐Ÿ‡บ๐Ÿ‡ธ USA
29.5-25.62%๐Ÿ‡บ๐Ÿ‡ธ USA
27.1-31.50%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-1.20-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-49.1-223.99%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.